Shin, D. H., Min, H., El-Naggar, A. K., Lippman, S. M., Glisson, B., & Lee, H. (2011). Akt/mammalian target of rapamycin counteract the antitumor activities of cixutumumab an anti-insulin-like growth factor I receptor monoclonal antibody.

Shin, Dong Hoon, Hye-Young Min, Adel K. El-Naggar, Scott M. Lippman, Bonnie Glisson, ja Ho-Young Lee. Akt/mammalian Target of Rapamycin Counteract the Antitumor Activities of Cixutumumab an Anti-insulin-like Growth Factor I Receptor Monoclonal Antibody. 2011.

Shin, Dong Hoon, et al. Akt/mammalian Target of Rapamycin Counteract the Antitumor Activities of Cixutumumab an Anti-insulin-like Growth Factor I Receptor Monoclonal Antibody. 2011.